Anti-Oncogenic Activity of Signalling-Defective Epidermal Growth Factor Receptor Mutants

REFERENCES

• Basu, A., M. Raghunath, S. Bishayee, and M. Das. 1989. Inhibition of tyrosine kinase activity of the epidermal growth factor (EGF) receptor by a truncated receptor form that binds to EGF: role for interreceptor interaction in kinase regulation. Mol. Cell. Biol. 9:671–677.
   PubMedGoogle Scholar
• Berger, M. S., C. Greenfield, W. J. Gullick, J. Haley, J. Downward, D. E. Neal, A. L. Harris, and M. D. Waterfield. 1987. Evaluation of epidermal growth factor receptors in bladder tumours. Br. J. Cancer 56:533–537.
   PubMed Web of Science ®Google Scholar
• Biasband, A. J., D. M. Gilligan, L. F. Winchell, S. T. Wong, N. C. Luetteke, K. T. Rogers, and D. C. Lee. 1990. Expression of the TGF-a integral membrane precursor induces transformation of nrk cells. Oncogene 5:1213–1221.
   PubMedGoogle Scholar
• Bordignon, C., S.-F. Yu, C. A. Smith, P. Hantzopoulos, G. E. Ungers, C. A. Keever, R. J. O'Reilly, and E. Gilboa. 1989. Retroviral vector-mediated high-efficiency expression of adenosine deaminase (ADA) in hematopoietic long-term cultures of ADA-deficient marrow cells. Proc. Natl. Acad. Sci. USA 86:6748–6752.
   PubMedGoogle Scholar
• Chou, C. K., T. J. Dull, D. S. Russell, R. Gherzi, D. Lebwohl, A. Ullrich, and O. M. Rosen. 1987. Human insulin receptors mutated at the ATP-binding site lack protein tyrosine kinase activity and fail to mediate postreceptor effects of insulin. J. Biol. Chem. 262:1842–1847.
   PubMed Web of Science ®Google Scholar
• Cochet, C., O. Kashles, E. M. Chambaz, I. Borrello, C. R. King, and J. Schlessinger. 1988. Demonstration of epidermal growth factor-induced receptor dimerization in living cells using a chemical covalent cross-linking agent. J. Biol. Chem. 263:3290–3295.
   PubMed Web of Science ®Google Scholar
• Derynck, R., D. V. Goeddel, A. Ullrich, J. U. Gutterman, R. D. Williams, T. S. Bringman, and W. H. Berger. 1987. Synthesis of mRNAs for transforming growth factors-α and -β and the epidermal growth factor receptor by human tumors. Cancer Res. 47:707–712.
   PubMed Web of Science ®Google Scholar
• Di Fiore, P. P., J. H. Pierce, T. P. Fleming, R. Hazan, A. Ullrich, C. R. King, J. Schlessinger, and S. A. Aaronson. 1987. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells. Cell 51:1063–1070.
   PubMed Web of Science ®Google Scholar
• Di Marco, E., J. H. Pierce, T. P. Fleming, M. H. Kraus, C. J. Molloy, S. A. Aaronson, and P. P. Di Fiore. 1989. Autocrine interaction between TGFa and the EGF-receptor: quantitative requirements for induction of the malignant phenotype. Oncogene 4:831–838.
   PubMed Web of Science ®Google Scholar
• Downward, J., P. Parker, and M. D. Waterfield. 1984. Autophosphorylation sites on the epidermal growth factor receptor. Nature (London) 311:483–485.
   PubMed Web of Science ®Google Scholar
• Fendly, B. M., M. Winget, R. M. Hudziak, M. T. Lipari, M. A. Napier, and A. Ullrich. 1990. Characterization of murine monoclonal antibodies reactive to either the human epidermal growth factor receptor or HER2/neu oncogene. Cancer Res. 50:1550–1558.
   PubMed Web of Science ®Google Scholar
• Frykberg, L., S. Palmieri, H. Beug, T. Graf, M. J. Hayman, and B. Vennstrom. 1983. Transforming capacities of avian erythroblastosis virus mutants deleted in the erbA or erbB oncogenes. Cell 32:227–238.
   PubMed Web of Science ®Google Scholar
• Fung, T., W. G. Lewis, H.-J. Kung, and L. B. Crittenden. 1983. Activation of the cellular oncogene c-erbB by LTR insertion: molecular basis for induction of erythroblastosis by avian leukosis virus. Cell 33:357–368.
   PubMed Web of Science ®Google Scholar
• Graf, T., B. Royer-Pokora, G. E. Schubert, and H. Beug. 1976. Evidence for the multiple oncogenic potential of cloned leukemia virus: in vitro and in vivo studies with avian erythroblastosis virus. Virology 71:423–433.
   PubMedGoogle Scholar
• Gullick, W. J., J. J. Marsden, N. Whittle, B. Ward, L. Bobrow, and M. D. Waterfield. 1986. Expression of epidermal growth factor receptors on human cervical, ovarian and vulval carcinomas. Cancer Res. 46:285–292.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., T. J. Dull, F. Bellot, E. Van Obberghen, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1988. Biological activities of EGF-receptor mutants with individually altered autophosphorylation sites. EMBO J. 7:3045–3052.
   PubMedGoogle Scholar
• Honegger, A. M., T. J. Dull, S. Felder, E. Van Obberghen, F. Bellot, D. Szapary, A. Schmidt, A. Ullrich, and J. Schlessinger. 1987. Point mutation at the ATP binding site of EGF receptor abolishes protein-tyrosine kinase activity and alters cellular routing. Cell 51:199–209.
   PubMed Web of Science ®Google Scholar
• Honegger, A. M., A. Schmidt, A. Ullrich, and J. Schlessinger. 1990. Evidence for epidermal growth factor-induced intermolecular autophosphorylation of the EGF receptor in living cells. Mol. Cell. Biol. 10:4035–4044.
   PubMed Web of Science ®Google Scholar
• Hudziak, R. M., J. Schlessinger, and A. Ullrich. 1987. Increased expression of the putative growth factor receptor pl85HER2 causes transformation and tumorigenesis of NIH 3T3 cells. Proc. Natl. Acad. Sci. USA 84:7159–7163.
   PubMed Web of Science ®Google Scholar
• Hudziak, R. M., and A. Ullrich. Submitted for publication.
   Google Scholar
• Kashles, O., Y. Yarden, R. Fischer, A. Ullrich, and J. Schlessinger. 1991. A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Mol. Cell. Biol. 11:1454–1463.
   PubMed Web of Science ®Google Scholar
• Keller, G., C. Paige, E. Gilboa, and E. F. Wagner. 1985. Expression of a foreign gene in myeloid and lymphoid cells derived from multipotent haematopoietic precursors. Nature (London) 318:149–154.
   PubMed Web of Science ®Google Scholar
• Kern, J. A., D. A. Schwartz, J. E. Nordberg, D. B. Weiner, M. I. Greene, L. Torney, and R. A. Robinson. 1990. pl85neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res. 50:5184–5191.
   PubMed Web of Science ®Google Scholar
• Khazaie, K., T. J. Dull, T. Graf, J. Schlessinger, A. Ullrich, H. Beug, and B. Vennström. 1988. Truncation of the human EGF receptor leads to differential transforming potentials in primary avian fibroblasts and erythroblasts. EMBO J. 7:3061–3071.
   PubMedGoogle Scholar
• Kris, R., I. Lax, W. Gullick, M. D. Waterfield, A. Ullrich, M. Fridkin, and J. Schlessinger. 1985. Antibodies against a synthetic peptide as a probe for the kinase activity of the avian EGF-R and v-erbB protein. Cell 40:619–625.
   PubMed Web of Science ®Google Scholar
• Lammers, R., E. Van Obberghen, R. Ballotti, J. Schlessinger, and A. Ullrich. 1990. Transphosphorylation as a possible mechanism for insulin and epidermal growth factor receptor activation. J. Biol. Chem. 265:16886–16890.
   PubMedGoogle Scholar
• Lax, L., R. Kris, I. Sasson, A. Ullrich, M. J. Hayman, H. Beug, and J. Schlessinger. 1985. Activation of c-erb-B in avian leukosis virus-induced erythroblastosis leads to the expression of a truncated EGF receptor kinase. EMBO J. 4:3179–3182.
   PubMedGoogle Scholar
• Lax, L., A. Mitra, C. Ravera, D. Hurwitz, M. Rubinstein, A. Ullrich, R. Stroud, and J. Schlessinger. 1991. EGF induces oligomerization of soluble, extracellular, ligand binding domain of EGF-receptor and a low resolution projection structure of the ligand binding domain. J. Biol. Chem. 266:13828–13833.
   PubMed Web of Science ®Google Scholar
• Libermann, T. A., H. R. Nusbaum, N. Razon, R. Kris, I. Lax, H. Soreq, N. Whittle, M. D. Waterfield, A. Ullrich, and J. Schlessinger. 1985. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin. Nature (London) 313:144–147.
   PubMed Web of Science ®Google Scholar
• Livneh, E., R. Prywes, O. Kashles, N. Reiss, I. Sasson, Y. Mory, A. Ullrich, and J. Schlessinger. 1986. Reconstitution of human epidermal growth factor receptors and its deletion mutants in cultured hamster cells. J. Biol. Chem. 260:12490–12497.
   Google Scholar
• Margolis, B. L., I. Lax, R. Kris, M. Dombalagian, A. M. Honegger, R. Howk, D. Givol, A. Ullrich, and J. Schlessinger. 1989. All autophosphorylation sites of epidermal growth factor (EGF) receptor and HER2/neu are located in their carboxyterminal tails. J. Biol. Chem. 264:10667–10671.
   PubMed Web of Science ®Google Scholar
• Markowitz, D., S. Goff, and A. Bank. 1988. A safe packaging line for gene transfer: separating viral genes on two different plasmids. J. Virol. 62:1120–1124.
   PubMed Web of Science ®Google Scholar
• McClain, D. A., H. Maegawa, J. Lee, T. J. Dull, A. Ullrich, and J. M. Olefsky. 1987. A mutant insulin receptor with defective tyrosine kinase displays no biologic activity and does not undergo endocytosis. J. Biol. Chem. 262:14663–14671.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., and C. Buttimore. 1986. Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production. Mol. Cell. Biol. 6:2895–2902.
   PubMed Web of Science ®Google Scholar
• Miller, A. D., M.-F. Law, and I. M. Verma. 1985. Generation of helper-free amphotropic retrovirus that transduce a dominantacting, methotrexate-resistant dihydrofolate reductase gene. Mol. Cell Biol. 5:431–437.
   PubMedGoogle Scholar
• Nocka, K., S. Msyumder, B. Chabot, P. Ray, M. Cervone, A. Bernstein, and P. Besmer. 1989. Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice—evidence for an impaired c-kit kinase in mutant mice. Genes Dev. 3:816–826.
   PubMed Web of Science ®Google Scholar
• Nocka, K., J. C. Tan, E. Chin, T. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9:1805–1813.
   PubMed Web of Science ®Google Scholar
• Prywes, R., E. Livneh, A. Ullrich, and J. Schlessinger. 1986. Mutations in the cytoplasmic domain of EGF receptor affect EGF binding and receptor internalization. EMBO J. 5:2179–2190.
   PubMedGoogle Scholar
• Reith, A. D., R. Rottapell, E. Giddens, C. Brady, L. Forrester, and A. Bernstein. 1990. ω mutant mice with mild or severe developmental defects contain distinct point mutations in the kinase domain of the c-kit receptor. Genes Dev. 4:390–400.
   PubMed Web of Science ®Google Scholar
• Riedel, H., S. Massoglia, J. Schlessinger, and A. Ullrich. 1988. Ligand activation of overexpressed epidermal growth factor receptors transforms NIH 3T3 mouse fibroblasts. Proc. Natl. Acad. Sci. USA 85:1477–1481.
   PubMed Web of Science ®Google Scholar
• Sainsbury, J. R. C., J. R. Farndon, G. V. Sherbert, and A. L. Harris. 1985. Epidermal growth factor receptors and oestrogen receptors in human breast cancer. Lancet i:364–366.
   Google Scholar
• Schlessinger, J. 1988. Signal transduction by allosteric receptor oligomerization. Trends Biochem. Sci. 13:443–447.
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., G. M. Clark, S. G. Wong, W. J. Levin, A. Ullrich, and W. L. McGuire. 1987. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science 235:177–182.
   PubMed Web of Science ®Google Scholar
• Slamon, D. J., W. Godolphin, L. A. Jones, J. A. Holt, S. G. Wong, D. E. Keith, W. J. Levin, S. G. Stuart, J. Udove, A. Ullrich, and M. F. Press. 1989. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science 244:707–712.
   PubMed Web of Science ®Google Scholar
• Stewart, C. L., S. Schuetze, S. Vanek, and E. F. Wagner. 1987. Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J. 6:383–388.
   PubMed Web of Science ®Google Scholar
• Tan, J. C., K. Nocka, P. Ray, P. Traktman, and P. Besmer. 1990. The dominant W42 spotting phenotype results from a missense mutation in the c-kit receptor kinase. Science 247:209–212.
   PubMedGoogle Scholar
• Taylor, S. I., A. Cama, H. Kadowaki, T. Kadowaki, and D. Accili. 1990. Mutations of the human insulin receptor gene. Trends Endocrinol. Metabol. 2:134–139.
   Google Scholar
• Ullrich, A., L. Coussens, J. S. Hayflick, T. J. Dull, A. Gray, A. W. Tam, J. Lee, Y. Yarden, T. A. Libermann, J. Schlessinger, J. Downward, E. L. V. Mayes, N. Whittle, M. D. Waterfield, and P. H. Seeburg. 1984. Human epidermal growth factor receptor cDNA sequence and aberrant expression of the amplified gene in A431 epidermoid carcinoma cells. Nature (London) 309:418–425.
   PubMed Web of Science ®Google Scholar
• Ullrich, A., and J. Schlessinger. 1990. Signal transduction by receptors with tyrosine kinase activity. Cell 61:203–212.
   PubMed Web of Science ®Google Scholar
• Velu, T. J., L. Beguinot, W. C. Vass, M. C. Willingham, G. T. Merlino, I. Pastan, and D. R. Lowy. 1987. Epidermal growth factor-dependent transformation by a human EGF receptor proto-oncogene. Science 237:1408–1410.
   PubMedGoogle Scholar
• von Rüden, T., and E. F. Wagner. 1988. Expression of functional human EGF receptor on murine bone marrow cells. EMBO J. 7:2749–2756.
   PubMedGoogle Scholar
• Walton, G. M., W. S. Chen, M. G. Rosenfeld, and G. N. Gill. 1990. Analysis of deletions of the carboxyl terminus of the epidermal growth factor receptor reveals self-phosphorylation at tyrosine 992 and enhanced in vivo tyrosine phosphorylation of cell substrates. J. Biol. Chem. 265:1750–1754.
   PubMedGoogle Scholar
• Yamamoto, T., N. Kamata, H. Kawano, S. Shimizu, T. Kuroki, K. Toyoshima, K. Rikimaru, N. Nomura, R. Ishizaki, I. Pastan, S. Gamou, and N. Shimizu. 1986. High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines. Cancer Res. 46:414–416.
   PubMed Web of Science ®Google Scholar
• Yarden, Y., and J. Schlessinger. 1987. Self-phosphorylation of epidermal growth factor receptor: evidence for a model of intermolecular allosteric activation. Biochemistry 26:1443–1451.
   PubMed Web of Science ®Google Scholar